Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV472
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,786
Award facts
- Contract value 100% obligated
- $30,786.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,786.03 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in medical product supply to federal healthcare systems.
This delivery order was issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the contractor to supply brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs globally. Dupixent is a prescription biologic medication used primarily for treating eczema, asthma, and other inflammatory conditions, representing the type of specialty pharmaceutical product routinely procured through this strategic contract vehicle to support Defense Health Agency and military treatment facility operations.
Quick answers
Who was awarded contract SPE2DR26FV472?
SPE2DR26FV472 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FV472 worth?
The government has obligated $30,786 on SPE2DR26FV472.
Is contract SPE2DR26FV472 an order under another contract?
Yes. SPE2DR26FV472 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV472 competed?
The extent of competition for SPE2DR26FV472 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award